A subscription to JoVE is required to view this content. Sign in or start your free trial.
This protocol demonstrates dextran imaging in live cells using continuous uptake and inverse images to optimize visualization of ruffling, macropinosome maturation, and analysis of dextran and other cell labelings.
Macropinocytosis is a highly conserved but still incompletely understood process that is essential for the uptake and ingestion of fluid, fluid-phase nutrients and other material in cells. The dramatic extension of cell surface ruffles, their closure to form macropinosomes, and the maturation of internalized macropinosomes are key events in this pathway that can be difficult to capture using conventional confocal imaging based on tracking a bolus of fluorescent cargo. Fluorescent dextrans are commonly used experimentally as fluid phase markers for macropinosomes and for other endocytic pathways. A method the lab has adopted to optimize the imaging of dextran uptake involves using live imaging of cells bathed in high concentrations of fluorescent dextran in the medium, with the unlabeled cells appearing in relief (as black). The cell ruffles are highlighted to visualize ruffle closure, and internalized macropinosomes appear as fluorescent vacuoles in the cell interior. This method is optimal for visualizing macropinosome features and allows for easy segmentation and quantification. This paper describes dual-labeling of pathways with different sized dextrans and the co-expression of lipid probes and fluorescent membrane proteins to demark macropinosomes and other endosomes. The detection of internalized dextran at an ultrastructural level using correlative light and electron microscopy (CLEM) is also demonstrated. These cell processes can be imaged using multiple live imaging modalities, including in 3D. Taken together, these approaches optimize macropinosome imaging for many different settings and experimental systems.
Most vertebrate cell types share the innate capacity for the non-selective uptake of fluid with predecessors throughout evolution, dating back to single-cell amoeba1. This highly conserved process of fluid-phase uptake by macropinocytosis (big drinking) is used by amoeba primarily for nutrient acquisition1, while in vertebrate cells, it can similarly be a supply route for obtaining nutrients under stress, and it is used by immune cells for the sampling and surveillance of tissue environments2. Macropinocytosis has features that distinguish it from other forms of endocytosis, including the distinct....
1. Preparation of cells on 35 mm glass-bottom dishes (Day 0)
The approach of imaging unlabeled live cells immersed in a high concentration of fluorescent dextran has several advantages over conventional imaging techniques for tracking macropinocytosis. By presenting the images in relief, the cell bodies appear as black and allow improved visualization of the dramatic cell surface ruffling against a bright, fluorescent background, followed by fluid-phase internalization of TMR dextran (70 kDa)-filled macropinosomes as depicted in Figure 1A. In this max.......
This paper describes variations on more traditional ways of using dextran labeling to track macropinocytosis, based on live imaging of cells bathed continuously in fluorescent dextran(s) and visualizing the uptake on the black background of unlabeled cells. The optimized protocol provides the means to distinguish between different intracellular vesicles and allows a spatial-temporal tracking of multiple macropinocytotic and endocytic cargos and proteins. The method of immersing cells in a dextran medium to monitor the dy.......
The authors thank Tatiana Khromykh for her expert technical assistance. Fluorescence imaging was performed in IMB Microscopy incorporating the Cancer Ultrastructure and Function Facility funded by the Australian Cancer Research Foundation; electron microscopy was performed in UQ's Centre for Microscopy and Microanalysis. Funding was received from the National Health and Medical Research Council of Australia (JLS APP1176209) and the Australian Research Council (DP180101910). NDC is supported as a CZI Imaging Scientist by grant number 2020-225648 from the Chan Zuckerberg Initiative DAF, an advised fund of Silicon Valley Community Foundation. YH was supported by a Ph....
Name | Company | Catalog Number | Comments |
2% Osmium Tetroxide | ProSciTech | EMS19192 | |
647-Transferrin | Molecular Probes, Invitrogen | Â T23366 | |
BV2 cells | Gift kindly given to us by Dr Liviu Bodea (Queensland Brain Institute) | - | |
CpG (Class B) B | Integrated DNA Technologies | Custom Order | |
Dextran Alexa Fluor 488Â at 10 kDa MW | Life Technology Australia Pty Ltd | D22910 | |
Dextran Alexa Fluor 647Â at 10 kDa MW | Life Technology Australia Pty Ltd | D22914 | |
Dextran Oregon Green 488 at 70 kDa MW | Life Technology Australia Pty Ltd | D1818 | |
Dextran Tetramethylrhodamine at 70 kDa MW | Life Technology Australia Pty Ltd | D7173 | |
DMEM medium with sodium pyruvate and L-glutamine | Gibco Invitrogen | #11995 | |
Fetal Calf serum | Interpath Services Pty Ltd | SFBS-F | |
Glutaraldehyde aqueous solution, EM Grade 25% | ProSciTech | C002 | |
Jeol 1011 electron microscope | JEOL | - | |
L-Glutamine | Gibco Invitrogen | 25030081 | |
Lipofectamine 2000 | Gibco Invitrogen | 11668019 | |
MatTek Glass Bottom Dish 35 mm, uncoated grid | MatTek Corporation | P35G-2-14-CGRD | |
MatTek glass bottom dishes 35 mm uncoated | MatTek Corporation | P35G-1.5-14C | |
MDA-MB 231 cells | ATCC | HTB-26 | |
Opti-MEM reduced serum medium | Thermo Fisher Scientific | 31985088 | |
Plasmid mCherry-2XFYVE | Gift kindly given to us by Dr Frederic Meunier (University of Queensland) | - | |
Plasmid mCherry-PLCδ-PH | Gift kindly given to us by Dr Frederic Meunier (University of Queensland) | - | |
Raw264.7 cells | ATCC | TIB-71 | |
RPMI medium 1640,without L-glutamine | Gibco Invitrogen | #21870 | |
Ultrapure LPS | Jomar Life Research Pte Ltd | TLR-3PELPS | |
Uranyl Acetate | ProSciTech | C079 | |
Zeiss inverted LSM880 confocal microscope | Zeiss | - |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved